NF Type 1 and Cancer Risk and Screening

An article by Sharon Reynolds from the National Cancer Institute highlights the importance of people with neurofibromatosis type 1 (NF1) to be diligent about paying attention to their bodies and symptoms to help detect cancer. NF1 is known to cause neurofibromas which are normally benign, however people with NF1 may be at a greater risk of developing certain cancers. One of those cancers being breast cancer. New guidelines suggest that those with NF1 should be screened for breast cancer as early as age 30 compared to the average recommended screening age of 40. Prevention and early detection are key to survival rates so just as the article advises, if you feel something do something, and talk with your doctor about your concerns. Sharon Reynolds article would be good resource to share with your doctor to start the conversation. For more information and to read this article in its entirety please visit the following link.

Recent Posts

  • Barriers to Healthcare Access and Psychosocial Experiences in Adults with Neurofibromatosis Type 1

    Offered by: University of Colorado AnschutzConducted by: Katelyn Glowinski, genetic counseling student, master’s program This research study is designed to gain a better understanding of healthcare barriers faced by adults with Neurofibromatosis Type 1 (NF1), as well as evaluate any associations between these barriers and your self-reported neuropsychiatric or mental health status. If you join... Read More
  • Where Belonging Can Lead: Rachel’s Journey with NF Midwest 

    Rachel was 13 when she first attended Camp NF.  At an age when so much was changing, camp gave her something she deeply needed: the chance to meet other young people who understood life with NF.  “NF camp gave me the opportunity to connect with others who had a shared experience and come to understand... Read More

Responses

Respond

Your email address will not be published. Required fields are marked *